2024 cohort data · Clinical outcomes

Success, measured with clarity.

EPIA combines clinical expertise, advanced embryology and individualized care protocols to deliver strong outcomes in fertility preservation and assisted reproduction.

Discuss your options View the data

How we report outcomes

Performance is benchmarked against global standards including SART and ESHRE. EPIA maintains a continuous internal audit of treatment cycles, stratified by age, indication and protocol type.

Vitrification outcomes

Egg freezing

Oocyte cryopreservation outcomes from EPIA's 2024 cohort.

Egg freezing outcomes
Metric	Cohort	Outcome
Average MII oocytes per cycle	Age <35	14.7
Post-thaw survival rate	MII oocytes	99.3%
ICSI fertilization rate	Post-thaw	78.6%
Blastocyst conversion rate	All	56.4%

Implantation rate per frozen embryo transfer
Age group	Implantation rate per frozen embryo transfer
Under 35	61.2%
35–37	52.8%
38–40	44.9%
Over 40	31.6%

Fresh and frozen transfers

In vitro fertilization

48.2%
Live birth rate per ET, all ages: 2.1
Average embryos transferred: 62%
PGT-A usage rate

Clinical pregnancy rate per embryo transfer
Age group	Clinical pregnancy rate per embryo transfer
Under 35	68.5%
35–37	59.7%
38–40	48.3%
Over 40	34.1%

Euploid embryo rate
Age group	Euploid embryo rate
Under 35	62%
35–37	52%
38–40	38%
Over 40	21%

Subset analysis · N=112 · 2024

Conceive Plus optimization protocol

Includes IV micronutrient therapy, TCM-aligned acupuncture and oral antioxidant supplementation with CoQ10, DHEA and myo-inositol.

91.7% vs. 75.4%

Enhanced oocyte maturity rate vs. non-prep cohort

Infrastructure & quality control

EmbryoScope time-lapse imaging
Vitrification using the Kitazato protocol
ICSI for all frozen-thawed oocytes
Laser-assisted hatching on Day 5 when required
Individualized GnRH-antagonist or mild stimulation
Monthly performance audits and annual data release

Regional & global context

Success benchmarks

A side-by-side view of EPIA's reported outcomes and published regional and global averages.

EPIA success benchmarks
Metric	EPIA	Asia regional avg	Global avg (SART/ESHRE)
Egg thaw survival	92.3%	~85%	90%
IVF pregnancy (age <35)	68.5%	~52%	56–60%
Live birth per ET	48.2%	~38%	40–45%
Euploid embryo rate (35–37)	52%	~42%	45–50%

Rates vary by age, diagnosis, treatment protocol and cohort. The egg-thaw figures above reflect the distinct cohorts as reported in the source dataset.

At a glance

What supports the results

Higher-than-average reported outcomes across IVF, egg freezing and embryo transfer
Evidence-based adjunct treatments with measurable biomarker improvements
State-of-the-art laboratory technology and strict clinical governance
Transparent reporting and outcomes-based care pathways

Your outcome starts with the right plan.

Speak with EPIA's fertility team about how age, diagnosis and treatment choices shape your individual chances of success.

Book a consultation

For anonymized cycle data or research partnerships, contact care@epiafertility.com.